| Bioactivity | Apoptosis inducer 29 (compund Y9) is an apoptosis inducer that exhibits antitumor effects in non-small cell lung cancer. Apoptosis inducer 29 selectively acidifies lysosomes and induces lysosomal dysfunction, with superior potency to Gboixn (HY-111651) in vitro and in vivo.[1]. |
| Formula | C33H46ClN3O3 |
| Molar Mass | 568.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yin J, et al. Y9, a Gboxin analog, displays anti-tumor effect in non-small cell lung cancer by inducing lysosomal dysfunction and apoptosis. Bioorg Chem. 2024 Dec;153:107820. |
Apoptosis inducer 29
CAS: F: C33H46ClN3O3 W: 568.19
Apoptosis inducer 29 (compund Y9) is an apoptosis inducer that exhibits antitumor effects in non-small cell lung cancer.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.